These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 23859513)

  • 1. [Dysbiosis, a new medical concept].
    Normand S; Secher T; Chamaillard M
    Med Sci (Paris); 2013; 29(6-7):586-9. PubMed ID: 23859513
    [No Abstract]   [Full Text] [Related]  

  • 2. The protein Nod2: an innate receptor more complex than previously assumed.
    Lecat A; Piette J; Legrand-Poels S
    Biochem Pharmacol; 2010 Dec; 80(12):2021-31. PubMed ID: 20643110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NOD2 regulation of Toll-like receptor responses and the pathogenesis of Crohn's disease.
    Watanabe T; Kitani A; Strober W
    Gut; 2005 Nov; 54(11):1515-8. PubMed ID: 16227353
    [No Abstract]   [Full Text] [Related]  

  • 4. [Etiology and molecular pathogenesis of Crohn disease].
    Schölmerich J
    Z Gastroenterol; 2002 Dec; 40 Suppl 2():68-70. PubMed ID: 12467015
    [No Abstract]   [Full Text] [Related]  

  • 5. Nod2 is essential for temporal development of intestinal microbial communities.
    Rehman A; Sina C; Gavrilova O; Häsler R; Ott S; Baines JF; Schreiber S; Rosenstiel P
    Gut; 2011 Oct; 60(10):1354-62. PubMed ID: 21421666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is Crohn's disease due to defective immunity?
    Korzenik JR
    Gut; 2007 Jan; 56(1):2-5. PubMed ID: 17172582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of smoking habits and CARD15 mutations on the onset of Crohn's disease.
    de Diego C; Alcántara M; Valle J; Repiso A; Carrobles JM; Martínez-Castro P
    Scand J Gastroenterol; 2006 Oct; 41(10):1209-11. PubMed ID: 16990207
    [No Abstract]   [Full Text] [Related]  

  • 8. Within you, without you: is gastroenterology ready to embrace the "exposome"?
    Sands BE
    Gastroenterology; 2012 Jun; 142(7):1403-4. PubMed ID: 22537647
    [No Abstract]   [Full Text] [Related]  

  • 9. NOD2 and defensins: translating innate to adaptive immunity in Crohn's disease.
    Peyrin-Biroulet L; Chamaillard M
    J Endotoxin Res; 2007; 13(3):135-9. PubMed ID: 17621555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomedicine. Puzzling out the pains in the gut.
    Marx J
    Science; 2007 Jan; 315(5808):33-5. PubMed ID: 17204619
    [No Abstract]   [Full Text] [Related]  

  • 11. Mapping the effects of genetic susceptibility and Mycobacterium avium subsp. paratuberculosis infection on Crohn's disease: strong but independent.
    Sieswerda LE; Bannatyne RM
    J Clin Microbiol; 2006 Mar; 44(3):1204-5. PubMed ID: 16517933
    [No Abstract]   [Full Text] [Related]  

  • 12. Genome-wide expression profiling identifies an impairment of negative feedback signals in the Crohn's disease-associated NOD2 variant L1007fsinsC.
    Billmann-Born S; Till A; Arlt A; Lipinski S; Sina C; Latiano A; Annese V; Häsler R; Kerick M; Manke T; Seegert D; Hanidu A; Schäfer H; van Heel D; Li J; Schreiber S; Rosenstiel P
    J Immunol; 2011 Apr; 186(7):4027-38. PubMed ID: 21335489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nod1 and Nod2 in innate immunity and human inflammatory disorders.
    Le Bourhis L; Benko S; Girardin SE
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1479-84. PubMed ID: 18031249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOD2 mutations and Crohn's disease: are Paneth cells and their antimicrobial peptides the link?
    Grimm MC; Pavli P
    Gut; 2004 Nov; 53(11):1558-60. PubMed ID: 15479670
    [No Abstract]   [Full Text] [Related]  

  • 15. MIP-3α expression in macrophages is NOD dependent.
    Hausmann M; Zeitler C; Weber A; Krebs M; Kellermeier S; Rosenstiel P; de Vallière C; Kosovac K; Fried M; Holler E; Rogler G
    Digestion; 2012; 85(3):192-201. PubMed ID: 22286692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CARD15/NOD2 mutations in Crohn's disease.
    Hugot JP
    Ann N Y Acad Sci; 2006 Aug; 1072():9-18. PubMed ID: 17057186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signalling pathways and molecular interactions of NOD1 and NOD2.
    Strober W; Murray PJ; Kitani A; Watanabe T
    Nat Rev Immunol; 2006 Jan; 6(1):9-20. PubMed ID: 16493424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nod-like receptors in the control of intestinal inflammation.
    Rubino SJ; Selvanantham T; Girardin SE; Philpott DJ
    Curr Opin Immunol; 2012 Aug; 24(4):398-404. PubMed ID: 22677577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NOD2-associated diseases: Bridging innate immunity and autoinflammation.
    Borzutzky A; Fried A; Chou J; Bonilla FA; Kim S; Dedeoglu F
    Clin Immunol; 2010 Mar; 134(3):251-61. PubMed ID: 19467619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of CARD15/NOD2 mutations in the Sicilian population.
    Renda MC; Cottone M
    Am J Gastroenterol; 2008 Jan; 103(1):248-9. PubMed ID: 18184136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.